Shareholders

As at 17 February, the number of shares in issue was 31,170,093.

 

Major shareholders*

As at 17 February 2021, shareholders holding more than 3% of the share capital of Cambridge Cognition Holdings plc were:

Name	No. of ordinary shares	% of existing share capital
Nigel Wray	4,851,547	15.56%
Canaccord Genuity Group Inc	3,116,475	10.00%
Michael Buxton	2,181,589	7.00%
Brett Gordon	1,595,000	5.12%
AXA Investment Managers S.A.	1,557,500	5.00%
W B Nominees	1,547,500	4.96%
Octopus Investments Nominees Ltd	1,429,771	4.59%
Lombard Odier	1,388,889	4.45%
Stephen Perring	1,016,000	3.26%

_{*The information in this table is based on publicly notified information and may not represent current holdings.}

 

Directors’ shareholdings

Director	No. of ordinary shares	% of existing share capital
Nicholas Walters	300,826	0.97%
Steven Powell	216,375	0.70%
Matthew Stork	125,000	0.40%
Debra Leeves	50,000	0.16%
Total	692,201	2.22%

 

Shares not in public hands

In terms of AIM Rules published February 2010 and insofar as it is aware, at 17 February 2021, 18.15% of the Company's AIM Securities was not in public hands. 

Restrictions in transfer of AIM securities

There are no restrictions on the transfer of Cambridge Cognition Holdings plc’s AIM securities.

Other exchanges and trading platforms

Cambridge Cognition Holdings plc has not applied or agreed to have any of its securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.